F275-0112 Screening compound: 3-[2-methyl-4-oxo-4-(4-phenylpiperazino)butyl]-1lambda~6~,2,4-benzothiadiazine-1,1(2H)-dione

F275-0112 Screening compound: 3-[2-methyl-4-oxo-4-(4-phenylpiperazino)butyl]-1lambda~6~,2,4-benzothiadiazine-1,1(2H)-dione
F275-0112 Screening compound: 3-[2-methyl-4-oxo-4-(4-phenylpiperazino)butyl]-1lambda~6~,2,4-benzothiadiazine-1,1(2H)-dione alternative view

Chemical Structure Depiction of ChemDiv screening compound F275-0112
3-[2-methyl-4-oxo-4-(4-phenylpiperazino)butyl]-1lambda~6~,2,4-benzothiadiazine-1,1(2H)-dione

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F275-0112

Molecular Formula

C22H26N4O3S (C22 H26 N4 O3 S)

Compound Name

3-[2-methyl-4-oxo-4-(4-phenylpiperazino)butyl]-1lambda~6~,2,4-benzothiadiazine-1,1(2H)-dione

IUPAC name

3-[2-methyl-4-oxo-4-(4-phenylpiperazin-1-yl)butyl]-2H-1lambda624-benzothiadiazine-11-dione

SMILES

CC(CC(N(CC1)CCN1c1ccccc1)=O)CC(N1)=Nc(cccc2)c2S1(=O)=O

InChI

InChI=1S/C22H26N4O3S/c1-17(15-21-23-19-9-5-6-10-20(19)30(28,29)24-21)16-22(27)26-13-11-25(12-14-26)18-7-3-2-4-8-18/h2-10,17H,11-16H2,1H3,(H,23,24)/t17-/m1/s1

InChI Key

JSPCJTUFXCSQSZ-QGZVFWFLSA-N

MDL Number (MFCD)

MFCD27111238

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

426.54

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.276

Distribution Coefficient, logD

1.836

Water Solubility, LogSw

-2.77

Polar Surface Area

70.277

Acid Dissociation Constant (pKa)

7.16

Base Dissociation Constant (pKb)

6.23

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

36.40

F275-0112 in Drug Discovery

Included in Screening Libraries

Protein Kinases Inhibitors Library (36801 compounds)

RNA-Protein Interaction Inhibitors Library (1986 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with F275-0112 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F275-0112?
Check Price and Availability of F275-0112, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F275-0112 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F275-0112
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F275-0112
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F275-0112 available by request